Bisantrene Combination for Resistant AML

NCT04989335 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myelogenous Leukemia, Acute

Interventions

DRUG: Bisantrene
DRUG: Fludarabine
DRUG: Clofarabine

Sponsor

Sheba Medical Center

Collaborators

[object Object]